2018 年 20 巻 p. 38-45
For the solution to regional problems and regional sustainable development, expectation is sent to the regional contribution activity of the company. It is necessary that the activity continues not a transient thing and is performed so that region develops continuously. However, It is said that when financial performance worsen, the company reduces CSR(Corporate Social Responsibility)activities and abolishes it. Is it similar in the pharmaceutical industry which main profession itself is directly connected to for society and regional problems solution? This paper clarifies what kind of the regional contribution activities of the pharmaceutical industry, how transforms in the stagnant period of the financial performance.